IDEAS home Printed from https://ideas.repec.org/e/pbo33.html
   My authors  Follow this author

Farasat A.S. Bokhari

Personal Details

First Name:Farasat
Middle Name:A.S.
Last Name:Bokhari
Suffix:
RePEc Short-ID:pbo33
Terminal Degree:2001 H. John Heinz III School of Public Policy and Management; Carnegie Mellon University (from RePEc Genealogy)

Affiliation

(50%) School of Economics
University of East Anglia

Norwich, United Kingdom
http://www.uea.ac.uk/eco/

: +44(0)1603 592065
+44(0)1603 4562592
Norwich NR4 7TI
RePEc:edi:esueauk (more details at EDIRC)

(50%) Centre for Competition Policy
University of East Anglia

Norwich, United Kingdom
http://www.ccp.uea.ac.uk/

: +44(0)1603 593715
+44(0)1603 591622
Norwich, NR4 7TJ
RePEc:edi:ccueauk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno Serra & Marc Suhrcke, 2016. "Assessing the impact of health care expenditures on mortality using cross-country data," Working Papers 128cherp, Centre for Health Economics, University of York.
  2. Farasat A.S. Bokhari & Helen Schnedier, 2009. "School accountability laws and the consumption of psychostimulants," Working Papers wp2009_03_02, Department of Economics, Florida State University, revised 08 Mar 2009.
  3. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
  4. Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret, 2005. "Government Health Expenditures and Health Outcomes," Working Papers wp2005_02_01, Department of Economics, Florida State University, revised May 2006.
  5. Farasat A.S. Bokhari & Rick Mayes & Richard M. Scheffler, 2003. "An analysis of the significant variation in psychostimulant use across the U.S," Working Papers wp2003_01_01, Department of Economics, Florida State University, revised Apr 2004.
  6. Farasat A.S. Bokhari, 2001. "Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catheterization," HEW 0110001, EconWPA.
  7. Ashish Arora & Farasat Bokhari, 1996. "Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution," Industrial Organization 9606002, EconWPA, revised 07 Jul 1998.
  8. Farasat Bokhari & George W. McCarthy, 1996. "Optimum Population -- A New Look: A Hamiltonian Approach Towards A Dynamic Analysis," Labor and Demography 9607002, EconWPA.

Articles

  1. Farasat Bokhari & Ian Wellwood & Anthony Rudd & Peter Langhorne & Martin Dennis & Charles Wolfe, 2014. "Selective admission into stroke unit and patient outcomes: a tale of four cities," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
  2. Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
  3. Bokhari, Farasat A.S. & Schneider, Helen, 2011. "School accountability laws and the consumption of psychostimulants," Journal of Health Economics, Elsevier, vol. 30(2), pages 355-372, March.
  4. Bokhari, Farasat A.S., 2009. "Managed care competition and the adoption of hospital technology: The case of cardiac catheterization," International Journal of Industrial Organization, Elsevier, vol. 27(2), pages 223-237, March.
  5. Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret, 2007. "Government health expenditures and health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 257-273.
  6. Ashish Arora & Farasat A. S. Bokhari, 2007. "OPEN VERSUS CLOSED FIRMS AND THE DYNAMICS OF INDUSTRY EVOLUTION -super-," Journal of Industrial Economics, Wiley Blackwell, vol. 55(3), pages 499-527, September.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Farasat A.S. Bokhari & Helen Schnedier, 2009. "School accountability laws and the consumption of psychostimulants," Working Papers wp2009_03_02, Department of Economics, Florida State University, revised 08 Mar 2009.

    Cited by:

    1. Anna Chorniy & Janet Currie & Lyudmyla Sonchak, 2017. "Exploding Asthma and ADHD Caseloads: The Role of Medicaid Managed Care," NBER Working Papers 23983, National Bureau of Economic Research, Inc.
    2. Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    3. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
    4. Marco Bertoni & Giorgio Brunello & Lorenzo Rocco, 2013. "When the Cat is Near, the Mice Won't Play: The Effect of External Examiners in Italian Schools," CEP Discussion Papers dp1191, Centre for Economic Performance, LSE.
    5. Patricia M. Anderson & Kristin F. Butcher & Diane Whitmore Schanzenbach, 2017. "Adequate (or Adipose?) Yearly Progress: Assessing the Effect of “No Child Left Behind” on Children's Obesity," Education Finance and Policy, MIT Press, vol. 12(1), pages 54-76, Winter.

  2. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.

    Cited by:

    1. Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Starving (or Fattening) the Golden Goose?: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
    2. Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
    3. Bokhari, Farasat A.S. & Schneider, Helen, 2011. "School accountability laws and the consumption of psychostimulants," Journal of Health Economics, Elsevier, vol. 30(2), pages 355-372, March.
    4. Gilad Sorek, 2015. "Health Insurance and Competition in Health Care Markets," Auburn Economics Working Paper Series auwp2015-03, Department of Economics, Auburn University.
    5. Peter Arcidiacono & Paul B. Ellickson & Peter Landry & David B. Ridley, 2013. "Pharmaceutical Followers," NBER Working Papers 19522, National Bureau of Economic Research, Inc.
    6. Duso, Tomaso & Herr, Annika & Suppliet, Moritz, 2014. "The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics," DICE Discussion Papers 137, University of Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).

  3. Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret, 2005. "Government Health Expenditures and Health Outcomes," Working Papers wp2005_02_01, Department of Economics, Florida State University, revised May 2006.

    Cited by:

    1. Azza Mohamed Hegazy, 2016. "Mobile Phone and Child Mortality: The Case of Developing Countries," International Journal of Economics and Financial Issues, Econjournals, vol. 6(3), pages 917-925.
    2. Austin, Kelly F. & DeScisciolo, Cristina & Samuelsen, Lene, 2016. "The Failures of Privatization: A Comparative Investigation of Tuberculosis Rates and the Structure of Healthcare in Less-Developed Nations, 1995–2010," World Development, Elsevier, vol. 78(C), pages 450-460.
    3. Micheal Kofi Boachie & K. Ramu, 2018. "Distribution of the benefits from public health expenditures in Ghana," Quality & Quantity: International Journal of Methodology, Springer, vol. 52(1), pages 415-430, January.
    4. Herrera, Santiago & Pang, Gaobo, 2005. "Efficiency of public spending in developing countries : an efficiency frontier approach," Policy Research Working Paper Series 3645, The World Bank.
    5. Wagstaff, Adam, 2008. "Fungibility and the impact of development assistance: evidence from Vietnam's health sector," Policy Research Working Paper Series 4800, The World Bank.
    6. Hauck, K. & Martin, S. & Smith, P.C., 2016. "Priorities for action on the social determinants of health: Empirical evidence on the strongest associations with life expectancy in 54 low-income countries, 1990–2012," Social Science & Medicine, Elsevier, vol. 167(C), pages 88-98.
    7. Jean-Paul Moatti & Bruno Ventelou, 2009. "Économie de la santé dans les pays en développement des paradigmes en mutation," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 241-256.
    8. Patrick GUILLAUMONT, 2009. "Aid effectiveness for poverty reduction:macroeconomic overview and emerging issues," Working Papers 200917, CERDI.
    9. ATAKE, Esso - Hanam, 2014. "Financement Public des dépenses de santé et survie infantile au Togo
      [Public funding of health expenditure and infant survival in Togo]
      ," MPRA Paper 59320, University Library of Munich, Germany, revised 26 Oct 2014.
    10. Patrick Guillaumont & Laurent Wagner, 2014. "Aid effectiveness for poverty reduction: lessons from cross-country analyses, with a special focus on vulnerable countries," Post-Print halshs-01112609, HAL.
    11. Gebregziabher, Fiseha & Nino-Zarazua, Miguel, 2014. "Social spending and aggregate welfare in developing and transition economies," WIDER Working Paper Series 082, World Institute for Development Economic Research (UNU-WIDER).
    12. Shinya Kajitani & Shuzo Nishimura & Keisuke Tokunaga, 2009. "Why Do the Japanese Enjoy Longevity? Do Health Care Expenditures Contribute it? (Revised Version of "The Impact of Healthcare Expenditures on Longevity in Japan: Evidence from Longitudinal, Prefe," Working Papers 15, Meisei University, School of Economics.
    13. Shinya Kajitani & Shuzo Nishimura & Keisuke Tokunaga, 2009. "The Impact of Healthcare Expenditures on Longevity in Japan: Evidence from Longitudinal, Prefectural-Level Data," Working Papers 13, Meisei University, School of Economics, revised Aug 2009.
    14. Victoria Fan and William Savedoff, 2014. "The Health Financing Transition: A Conceptual Framework and Empirical Evidence - Working Paper 358," Working Papers 358, Center for Global Development.
    15. Craig Gallet, 2009. "The Determinants of AIDS Mortality: Evidence from a State-Level Panel," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(4), pages 425-436, December.
    16. Kaushal, Kaushalendra Kumar & F Ram, Faujdar Ram & Abhishek, Abhishek Singh, 2013. "Public Spending on Health and Childhood Mortality in India," MPRA Paper 48680, University Library of Munich, Germany.
    17. Yusuke Kamiya, 2010. "Determinants of Health in Developing Countries:Cross-Country Evidence," OSIPP Discussion Paper 10E009, Osaka School of International Public Policy, Osaka University.
    18. Sefa Awaworyi Churchill & Janet Exornam Ocloo & Diana Siawor-Robertson, 2017. "Ethnic Diversity and Health Outcomes," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 134(3), pages 1077-1112, December.
    19. Enami, Ali, 2016. "Determinants of Child Mortality in Africa: A Methodological Discussion," MPRA Paper 68671, University Library of Munich, Germany.
    20. Fan, Victoria Y. & Savedoff, William D., 2014. "The health financing transition: A conceptual framework and empirical evidence," Social Science & Medicine, Elsevier, vol. 105(C), pages 112-121.
    21. Marwa Farag & A. Nandakumar & Stanley Wallack & Dominic Hodgkin & Gary Gaumer & Can Erbil, 2013. "Health expenditures, health outcomes and the role of good governance," International Journal of Health Economics and Management, Springer, vol. 13(1), pages 33-52, March.
    22. Alassane DRABO & Christian EBEKE, 2010. "Remittances, Public Health Spending and Foreign Aid in the Access to Health Care Services in Developing Countries," Working Papers 201004, CERDI.
    23. Bienvenido Ortega & Jesús Sanjuán & Antonio Casquero, 2017. "Determinants of efficiency in reducing child mortality in developing countries. The role of inequality and government effectiveness," Health Care Management Science, Springer, vol. 20(4), pages 500-516, December.
    24. Sweidan, Osama D. & Alwaked, Ahmed A., 2016. "Economic development and the energy intensity of human well-being: Evidence from the GCC countries," Renewable and Sustainable Energy Reviews, Elsevier, vol. 55(C), pages 1363-1369.
    25. Brosio, Giorgio & Zanola, Roberto, 2008. "The welfare costs of national standards: a contribution to the debate on the outcomes of de/centralization," POLIS Working Papers 113, Institute of Public Policy and Public Choice - POLIS.
    26. ATAKE, Esso - Hanam, 2014. "Financement Public des dépenses de santé et survie infantile au Togo
      [Public funding of health expenditure and infant survival in Togo]
      ," MPRA Paper 59516, University Library of Munich, Germany, revised 23 Oct 2014.
    27. AfDB AfDB, 2007. "Working Paper 91 - Health Expenditures and Health Outcomes in Africa," Working Paper Series 2224, African Development Bank.
    28. Craig Arthur Gallet, 2017. "The Impact of Public Health Spending on California STD Rates," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 23(2), pages 149-159, May.
    29. Awaworyi Churchill, Sefa & Ocloo, Janet Exornam & Siawor-Robertson, Diana, 2015. "Ethnic diversity makes me sick! An examination of ethnic diversity’s effect on health outcomes," EconStor Preprints 123721, ZBW - German National Library of Economics.
    30. Mamoon, Dawood & Arshed, Noman & Raza, Sidra, 2015. "Investments in Health and Education Help Save Lives," MPRA Paper 82495, University Library of Munich, Germany.
    31. Marwa Farag & A. NandaKumar & Stanley Wallack & Dominic Hodgkin & Gary Gaumer & Can Erbil, 2012. "The income elasticity of health care spending in developing and developed countries," International Journal of Health Economics and Management, Springer, vol. 12(2), pages 145-162, June.
    32. AfDB AfDB, 2007. "Working Paper 91 - Health Expenditures and Health Outcomes in Africa," Working Paper Series 2304, African Development Bank.
    33. Jessica Ochalek & James Lomas & Karl Claxton, 2015. "Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data," Working Papers 122cherp, Centre for Health Economics, University of York.
    34. Subhalaxmi Mohapatra, 2017. "Health inequity and health outcome: a causal linkage study of low and middle income countries," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(6), pages 2475-2488, November.
    35. Davide Golinelli & Fabrizio Toscano & Andrea Bucci & Jacopo Lenzi & Maria Pia Fantini & Nicola Nante & Gabriele Messina, 2017. "Health Expenditure and All-Cause Mortality in the ‘Galaxy’ of Italian Regional Healthcare Systems: A 15-Year Panel Data Analysis," Applied Health Economics and Health Policy, Springer, vol. 15(6), pages 773-783, December.
    36. Santiago Herrera & Gaobo Pang, 2006. "How Efficient is Public Spending in Education?," ENSAYOS SOBRE POLÍTICA ECONÓMICA, BANCO DE LA REPÚBLICA - ESPE, vol. 24(51), pages 136-201, June.
    37. Jessica Ochalek & Karl Claxton & Paul Revill & Mark Sculpher & Alexandra Rollinger, 2016. "Supporting the development of an essential health package: principles and initial assessment for Malawi," Working Papers 136cherp, Centre for Health Economics, University of York.
    38. Gallet, Craig A. & Doucouliagos, Hristos, 2017. "The impact of healthcare spending on health outcomes: A meta-regression analysis," Social Science & Medicine, Elsevier, vol. 179(C), pages 9-17.
    39. M. M. Goel, Ishu Garg, 2016. "Public Expenditure On Health And Its Impact On Health Infrastructure And Health Status In Haryana," Working papers 2016-09-04, Voice of Research.
    40. Dhiman Das, 2017. "Public expenditure and healthcare utilization: the case of reproductive health care in India," International Journal of Health Economics and Management, Springer, vol. 17(4), pages 473-494, December.
    41. Keita, Moussa, 2013. "Standards of living and health status: the socioeconomic determinants of life expectancy gain in sub-Saharan Africa," MPRA Paper 57553, University Library of Munich, Germany.
    42. Beth Woods & Paul Revill & Mark Sculpher & Karl Claxton, 2015. "Country-level cost-effectiveness thresholds: initial estimates and the need for further research," Working Papers 109cherp, Centre for Health Economics, University of York.
    43. Boachie, Micheal Kofi & Ramu, K., 2015. "Public Health Expenditure and Health Status in Ghana," MPRA Paper 66371, University Library of Munich, Germany.
    44. Michele Capriati, 2011. "Public Expenditure and Human Development in the Italian Regions," QA - Rivista dell'Associazione Rossi-Doria, Associazione Rossi Doria, issue 2, June.

  4. Ashish Arora & Farasat Bokhari, 1996. "Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution," Industrial Organization 9606002, EconWPA, revised 07 Jul 1998.

    Cited by:

    1. Suma Athreye, 1997. "On Markets in Knowledge," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 1(2), pages 231-253, June.

Articles

  1. Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
    See citations under working paper version above.
  2. Bokhari, Farasat A.S. & Schneider, Helen, 2011. "School accountability laws and the consumption of psychostimulants," Journal of Health Economics, Elsevier, vol. 30(2), pages 355-372, March.
    See citations under working paper version above.
  3. Bokhari, Farasat A.S., 2009. "Managed care competition and the adoption of hospital technology: The case of cardiac catheterization," International Journal of Industrial Organization, Elsevier, vol. 27(2), pages 223-237, March.

    Cited by:

    1. Barros, Pedro Pita & Martinez-Giralt, Xavier, 2010. "Technological adoption in health care," FEUNL Working Paper Series wp545, Universidade Nova de Lisboa, Faculdade de Economia.
    2. Barros Pedro Pita & Martinez-Giralt Xavier, 2015. "Technological Adoption in Health Care – The Role of Payment Systems," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 15(2), pages 709-745, April.
    3. Rosella Levaggi & Michele Moretto & Paolo Pertile, 2010. "Static and Dynamic Efficiency of Irreversible Health Care Investments under Alternative Payment Rules," Working Papers 2010.130, Fondazione Eni Enrico Mattei.
    4. Finocchiaro Castro, Massimo & Guccio, Calogero & Pignataro, Giacomo & Rizzo, Ilde, 2014. "The effects of reimbursement mechanisms on medical technology diffusion in the hospital sector in the Italian NHS," Health Policy, Elsevier, vol. 115(2), pages 215-229.
    5. Bisceglia, Michele & Cellini, Roberto & Grilli, Luca, 2017. "Regional regulators in healthcare service under quality competition: A game theoretical model," MPRA Paper 80507, University Library of Munich, Germany.
    6. Weech-Maldonado, Robert & Elliott, Marc N. & Pradhan, Rohit & Schiller, Cameron & Dreachslin, Janice & Hays, Ron D., 2012. "Moving towards culturally competent health systems: Organizational and market factors," Social Science & Medicine, Elsevier, vol. 75(5), pages 815-822.

  4. Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret, 2007. "Government health expenditures and health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 257-273.
    See citations under working paper version above.
  5. Ashish Arora & Farasat A. S. Bokhari, 2007. "OPEN VERSUS CLOSED FIRMS AND THE DYNAMICS OF INDUSTRY EVOLUTION -super-," Journal of Industrial Economics, Wiley Blackwell, vol. 55(3), pages 499-527, September.

    Cited by:

    1. Éric Darmon & Dominique Torre, 2014. "Open Source, Dual Licensing and Software Competition," Economics Working Paper Archive (University of Rennes 1 & University of Caen) 201405, Center for Research in Economics and Management (CREM), University of Rennes 1, University of Caen and CNRS.
    2. Bottai, Carlo, 2015. "Open Innovation in a Model à la Hotelling," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201526, University of Turin.
    3. Kevin Boudreau, 2010. "Open Platform Strategies and Innovation: Granting Access vs. Devolving Control," Management Science, INFORMS, vol. 56(10), pages 1849-1872, October.
    4. Gastón Llanes & Ramiro de Elejalde, 2009. "Industry Equilibrium with Open Source and Proprietary Firms," Harvard Business School Working Papers 09-149, Harvard Business School.
    5. Netsanet Haile & Jörn Altmann, 2017. "Evaluating Investments in Portability and Interoperability between Software Service Platforms," TEMEP Discussion Papers 2017136, Seoul National University; Technology Management, Economics, and Policy Program (TEMEP), revised May 2017.
    6. Yu Wang & Yu Chen & Bonwoo Koo, 2017. "Open Source and Competition Strategy Under Network Effects," Graz Economics Papers 2017-03, University of Graz, Department of Economics.
    7. Greenstein, Shane, 2010. "Innovative Conduct in Computing and Internet Markets," Handbook of the Economics of Innovation, Elsevier.
    8. Selam Abrham Gebregiorgis & Jorn Altmann, 2012. "IT Service Platforms: Their Value Creation Model and the Impact of their Level of Openness on their Adoption," TEMEP Discussion Papers 201295, Seoul National University; Technology Management, Economics, and Policy Program (TEMEP), revised Jun 2012.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 7 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (4) 2001-10-09 2006-09-11 2009-05-23 2016-04-16
  2. NEP-COM: Industrial Competition (1) 2009-05-23
  3. NEP-EDU: Education (1) 2009-06-03
  4. NEP-ENV: Environmental Economics (1) 1998-10-02
  5. NEP-MKT: Marketing (1) 2009-05-23
  6. NEP-PBE: Public Economics (1) 2006-09-11

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Farasat A.S. Bokhari should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.